EDGAR Filing Documents for 0001628280-24-023874

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001628280-24-023874

Filing Date

2024-05-17

Accepted

2024-05-16 19:18:55

Documents

Period of Report

2024-03-31

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	ffntf-20240331.htm iXBRL	10-Q	985477
2	EX-31.1	ffntf03312024exhibit311.htm	EX-31.1	12736
3	EX-31.2	ffntf03312024exhibit312.htm	EX-31.2	12948
4	EX-32.1	ffntf03312024exhibit321.htm	EX-32.1	12038
	Complete submission text file	0001628280-24-023874.txt		7359644

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	ffntf-20240331.xsd	EX-101.SCH	73163
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	ffntf-20240331_cal.xml	EX-101.CAL	105735
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	ffntf-20240331_def.xml	EX-101.DEF	317627
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	ffntf-20240331_lab.xml	EX-101.LAB	689116
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	ffntf-20240331_pre.xml	EX-101.PRE	501674
99	EXTRACTED XBRL INSTANCE DOCUMENT	ffntf-20240331_htm.xml	XML	958307

Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054

Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067

4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 834168417 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 24957323
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)